The impact of implementation of neuromuscular blockade monitoring standards in a surgical intensive care unit

American Surgeon

Volumn 62, Issue 6, 1996, Pages 503-506

  Frankel, Heidi ^a,b   Jeng, James ^a   Tilly, Elena ^a   Andre, Arthur St ^a   Champion, Howard ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATRACURIUM; NEUROMUSCULAR BLOCKING AGENT; VECURONIUM;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTINUOUS INFUSION; COST EFFECTIVENESS ANALYSIS; DRUG MONITORING; FEMALE; HUMAN; INTENSIVE CARE UNIT; MALE; MUSCLE TWITCH; NERVE STIMULATION; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR DISEASE; PATIENT MONITORING; ULNAR NERVE;

AGED; ATRACURIUM; COST-BENEFIT ANALYSIS; DRUG THERAPY; ELECTROLYTES; FEMALE; HUMANS; INCIDENCE; INTENSIVE CARE; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; MUSCLE CONTRACTION; MUSCLE, SKELETAL; NEUROMUSCULAR DISEASES; NEUROMUSCULAR JUNCTION; NEUROMUSCULAR NONDEPOLARIZING AGENTS; PARALYSIS; PROSPECTIVE STUDIES; REHABILITATION; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES; RISK FACTORS; THUMB; VECURONIUM BROMIDE;

EID: 0029948670     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Levin N, Dillon JB. Status asthmaticus and pancuronium bromide. JAMA 1972;222:1265-8.
2. Rozien MF, Feeley TW. Pancuronium bromide. Ann Int Med 1978;88:64-8.
3. Torres CF, Maniscalco WM, Agostinelli T. Muscle weakness and atrophy following prolonged paralysis with pancuronium bromide in neonates. Ann Neurol 1985;18:403.
4. Rutledge ML, Hawkins EP, Langston C. Skeletal muscle growth failure induced in premature newborn infants by prolonged pancuronium treatment. J Ped 1986;109:883-6.
5. Op de Coul A, Lambregts P, Korman J, et al. Neuromuscular complications in patients given pancuronium during artificial ventilation. Clin Neurol Neurosurg 1985;87:17-22.
6. Vandenbrom RG, Wienda JH. Pancuronium bromide in the intensive care unit: A case of overdose. Anesthesiology 1988;69: 995-7.
7. Haas JL, Shaefer MS, Miwa LJ, et al. Prolonged paralysis associated with long-term pancuronium use. Pharmacol Ther 1989; 9:154-7.
8. Rossiter A, Sauney PF, McGowan S, Corvajal P. Pancuronium-induced prolonged neuromuscular blockade. Crit Care Med 1991;19:1583-7.
9. Sinclair JF, Malcolm GA, Stevenson JP, Holworth D. Prolonged neuromuscular blockade in an infant. Anesthesiology 1987; 42:1020.
10. Subramony SH, Carpenter DE, Ranji S, et al. Myopathy and prolonged neuromuscular blockade after lung transplant. Crit Care Med 1991;19:1580-2.
11. Belafsky MA, Klawans HL. Prolonged neuromuscular blockade with pancuronium bromide in a young, healthy woman. Anesthesiology 1989;40:285.
12. Camp CE, Tessen J, Adenwala J, Joyce TM III. Vecuronium and prolonged neuromuscular blockade in postpartum patients. Anesthesiology 1987;67:1006-8.
13. Shanks AB, Long T, Aitkenhead AR. Prolonged neuromuscular blockade following vecuronium. Br J Anesth 1985;57:807-10.
14. Partridge BL, Abrams JH, Bazemore C, Rubin R. Prolonged neuromuscular blockade after long-term infusion of vecuronium bromide in the intensive care unit. Crit Care Med 1990;18:1177-9.
15. Segredo V, Matthay MA, Sharma ML, et al. Prolonged neuromuscular blockade after long-term administration of vecuronium in two critically ill patients. Anesthesiology 1990;72:566-70.
16. Pascucci RC. Prolonged weakness after extended mechanical ventilation in a child. Crit Care Med 1990;18:1181-2.
17. Margolis BD, Khachikian D, Friedman Y, Garrard C. Prolonged reversible quadriparesis in mechanically ventilated patients who received long-term infusions of vecuronium. Chest 1991;100: 877-8.
18. Gooch JL, Suchyta MR, Balbierz JM, et al. Prolonged paralysis after treatment with neuromuscular junction blocking agents. Crit Care Med 1991;19:1125-30.
19. Segredo V, Caldwell JE, Matthay MA, et al. Persistent paralysis in critically ill patients after long-term administration of vecuronium. N Engl J Med 1992;327:524-8.
20. Kupfer Y, Namba T, Kaldawi E, Tessler S. Prolonged weakness after long-term infusion of vecuronium. Ann Int Med 1992;117:489-90.
21. Vanderheyden BA, Reynolds HN, Gerold KB, Emanuele T. Prolonged paralysis after long-term vecuronium infusion. Crit Care Med 1992;20:304-7.
22. Wadon AJ, Dogra S, Anend S. Atracurium infusion in the intensive care unit. Br J Anaesth 1986;58:645.
23. Yale PM, Flynn PJ, Arnold RW, et al. Clinical experience and plasma laudanosine concentrations during the infusion of atracurium in the intensive care unit. Br J Anaesth 1987;59:211-7.
24. Fuhrman TM. Prolonged paralysis after long-term vecuronium infusion. Crit Care Med 1992;11:1623-4.
25. Hansen-Flaschen R, Cohen J, Raps EC. Neuromuscular blockade in the intensive care unit: More than we bargained for. Annu Rev Respir Dis 1993;147:234-6.
26. Isenstein DA, Venner DS, Duggan J. Neuromuscular blockade in the intensive care unit. Chest 1992;102:1258-66.
27. Durbin CG. Neuromuscular blocking agents and sedative drugs. Crit Care Clin 1991;7:489.
28. Coursin DB. Neuromuscular blockade: Should patients be relaxed in the ICU? Chest 1992;102:988-9.
29. Pedersen T, Viby-Mogensen J, Berg V, et al. Does perioperative tactile evaluation of the train-of-four response influence the frequency of postoperative residual neuromuscular blockade? Anesthesiology 1990;73:835-7.